Image de couverture de livre

Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Thanaboon Chaemsupaphan, Rupert W. Leong, Niels Vande Casteele, Cynthia H. Seow
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
par: Christy Riggott, et autres
Publié: (2024)

Inflammatory bowel disease in 2024 and beyond
par: Richard B. Gearry, et autres
Publié: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
par: Tsz Hong Yiu, et autres
Publié: (2024)

Review article: Prevention of inflammatory bowel disease—The path forward
par: Sérgio Bronze, et autres
Publié: (2024)

Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
par: Nurulamin M. Noor, et autres
Publié: (2024)

Review article: Evidence‐based dietary management of inflammatory bowel disease
par: Peter R. Gibson, et autres
Publié: (2024)

Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
par: Arta Aliu, et autres
Publié: (2024)

Letter: From Safety to Precision—Optimising the Use of GLP‐1 Receptor Agonists in Gastroenterology
par: Joëlle St‐Pierre, et autres
Publié: (2026)

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?
par: Ayesha Shah, et autres
Publié: (2024)

Editorial: GLP‐1 receptor agonists in inflammatory bowel disease—Is it time?
par: Konstantinos Arvanitakis, et autres
Publié: (2024)

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?
par: Agnes Hiu Yan Ho, et autres
Publié: (2024)

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply
par: Abhinav Vasudevan, et autres
Publié: (2024)

Letter: Allostatic load—A potential key in the development of inflammatory bowel disease
par: Maryam Kharal, et autres
Publié: (2024)

Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
par: Jianhui Zhao, et autres
Publié: (2024)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease—authors' reply
par: Abhinav Vasudevan, et autres
Publié: (2024)

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium
par: Amanda Ricciuto, et autres
Publié: (2024)

Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
par: Léa Sequier, et autres
Publié: (2024)

Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
par: Carl Eriksson, et autres
Publié: (2024)

Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease
par: R. M. Mathias, et autres
Publié: (2024)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
par: Iris Barth, et autres
Publié: (2024)

Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon
par: D. Bogatic, et autres
Publié: (2024)

Review article: Oesophageal disorders in chronic liver disease
par: Francisco Idalsoaga, et autres
Publié: (2024)

Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
par: Aakash Desai, et autres
Publié: (2024)

The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study
par: Fangyuan Jiang, et autres
Publié: (2024)

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
par: Kyuwon Kim, et autres
Publié: (2024)

Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
par: Rie Louise Møller Nordestgaard, et autres
Publié: (2024)

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy
par: Laura Kivelä, et autres
Publié: (2024)

Performance of bowel preparation quality scales in patients with Crohn's disease
par: Virginia Solitano, et autres
Publié: (2024)

Review article: Diagnosis and management of laryngopharyngeal reflux
par: Amanda J. Krause, et autres
Publié: (2024)

Clinical Trial: Association Between Early Disease Clearance and Long‐Term Outcomes—4‐Year Results From the Phase 3 UNIFI Study of Ustekinumab in Ulcerative Colitis
par: Silvio Danese, et autres
Publié: (2025)

Meta‐Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease
par: Quinn Goddard, et autres
Publié: (2025)

Review article: Evaluation and care of the critically ill patient with cirrhosis
par: Iva Kosuta, et autres
Publié: (2024)

Review article: advances in the diagnosis and management of anorectal motility disorders
par: Dariush Shahsavari, et autres
Publié: (2024)

Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound
par: Cathy Lu, et autres
Publié: (2024)

Review article: Telecare in gastroenterology—Within the COVID‐19 pandemic and beyond
par: Fatima Hakak, et autres
Publié: (2024)

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
par: Camille Lupianez‐Merly, et autres
Publié: (2024)

Review article: Current status and future directions of ingestible electronic devices in gastroenterology
par: Phoebe A. Thwaites, et autres
Publié: (2024)

Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update
par: Lindsay M. Clarke, et autres
Publié: (2024)

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
par: Danielle Adebayo, et autres
Publié: (2024)

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood
par: Paul Henderson
Publié: (2024)